Evidence map›Paper›PMID 38243266›Full record

ArticleTrials2024

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial.

Jing Wang, Lisa V Doan, Deborah Axelrod, John Rotrosen, Binhuan Wang, Hyung G Park, Robert R Edwards, Michele Curatolo, Carina Jackman, Raven Perez and 1 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05037123 (Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05037123 phase3active not recruitingnot on this map

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

TypeinterventionalSponsorNYU Langone HealthRan2022 to 2026Enrolled765ConditionsChronic Postsurgical PainArmsContinuous ketamine infusion, Ketamine + Saline, Placebo
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jing WangDepartment of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY, USA. jing.wang2@nyulangone.org.
Lisa V DoanDepartment of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY, USA. lisa.doan@nyulangone.org.ORCID http://orcid.org/0000-0002-7833-1753
Deborah AxelrodDepartment of Surgery, NYU Grossman School of Medicine, New York, NY, USA.
John RotrosenDepartment of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
Binhuan WangDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Hyung G ParkDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Robert R EdwardsDepartment of Anesthesia, Brigham and Women's Hospital, Boston, MA, USA.
Michele CuratoloDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.
Carina JackmanDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Raven PerezDepartment of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY, USA.
NCATS Trial Innovation Network
New York University · USBrigham and Women's Hospital · USUniversity of Utah · USUniversity of Washington · US

Funding

COVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., HERNANDEZ, ADRIAN · 2016 to 2022
$177.0M
Utah Trial Innovation CenterU24TR001597 · NCATS · UNIVERSITY OF UTAH · PI DEAN, JONATHAN MICHAEL · 2016 to 2022
$39.6M
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN SupplementU24TR001609 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2016 to 2022
$36.3M
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL SupplementU24TR001579 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, PAUL A., WILKINS, CONSUELO HOPKINS · 2016 to 2022
$34.1M
HEAL Sickle Cell and CDE SupplementU24TR004315 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DWYER, JAMIE P., SWARD, KATHERINE ANN · 2022 to 2025
$13.8M
Optimizing the use of ketamine to reduce chronic postsurgical painUH3CA261067 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DOAN, LISA, WANG, JING · 2021 to 2024
$5.2M
NCATS NIH HHS U24 TR001579NCATS NIH HHS U24TR001579-06S1NCATS NIH HHS U24 TR001597NCATS NIH HHS U24TR001597-06S1NCATS NIH HHS U24 TR001608NCATS NIH HHS U24TR001608-05S3NCATS NIH HHS U24 TR001609NCATS NIH HHS U24TR001609NCATS NIH HHS U24 TR004315NCI NIH HHS UH3 CA261067NCI NIH HHS UH3CA261067
6 · The paper itself

Abstract

backgroundMastectomies are commonly performed and strongly associated with chronic postsurgical pain (CPSP), more specifically termed postmastectomy pain syndrome (PMPS), with 25-60% of patients reporting pain 3 months after surgery. PMPS interferes with function, recovery, and compliance with adjuvant therapy. Importantly, it is associated with chronic opioid use, as a recent study showed that 1 in 10 patients continue to use opioids at least 3 months after curative surgery. The majority of PMPS patients are women, and, over the past 10 years, women have outpaced men in the rate of growth in opioid dependence. Standard perioperative multimodal analgesia is only modestly effective in prevention of CPSP. Thus, interventions to reduce CPSP and PMPS are urgently needed. Ketamine is well known to improve pain and reduce opioid use in the acute postoperative period. Additionally, ketamine has been shown to control mood in studies of anxiety and depression. By targeting acute pain and improving mood in the perioperative period, ketamine may be able to prevent the development of CPSP.

methodsKetamine analgesia for long-lasting pain relief after surgery (KALPAS) is a phase 3, multicenter, randomized, placebo-controlled, double-blind trial to study the effectiveness of ketamine in reducing PMPS. The study compares continuous perioperative ketamine infusion vs single-dose ketamine in the postanesthesia care unit vs placebo for reducing PMPS. Participants are followed for 1 year after surgery. The primary outcome is pain at the surgical site at 3 months after the index surgery as assessed with the Brief Pain Inventory-short form pain severity subscale. DISCUSSION: This project is part of the NIH Helping to End Addiction Long-term (HEAL) Initiative, a nationwide effort to address the opioid public health crisis. This study can substantially impact perioperative pain management and can contribute significantly to combatting the opioid epidemic.

trial registrationClinicalTrials.gov NCT05037123. Registered on September 8, 2021.

Indexed as

AnalgesiaBreast NeoplasmsChronic PainKetamineOpioid-Related DisordersAnalgesicsAnalgesics, OpioidClinical Trials, Phase III as TopicDouble-Blind MethodFemaleHumansMaleMastectomyMulticenter Studies as TopicPain ManagementPostoperative PainAnalgesicsAnalgesics, OpioidKetamineChronic postsurgical painKetamineNon-opioidPostmastectomy pain syndromePostoperative pain

Identifiers

PMID38243266
PMCPMC10797799
OpenAlexW4391034457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.